Elixir Associates reposted this
Headhunting Talented Individuals within Clinical Operations & Clinical Development for growing organizations across the US & Europe
Lantern Pharma Inc. (Nasdaq: LTRN) Remarkable Phase 2 Trial Update! 🚀 Exciting news from the clinical research world as Lantern Pharma's HARMONIC™ trial shows promising results for non-smokers with advanced NSCLC. Their novel drug, LP-300, combined with chemotherapy, has demonstrated significant potential 📊 The initial patient cohort reported positive safety and efficacy outcomes, with a high clinical benefit rate and no unexpected adverse events. Lantern's AI platform, RADR®, has been instrumental in this success, helping with target validation and patient identification. This progress gives encouragement, especially for patients with limited treatment options after TKI therapy 💊 #LanternPharma #Oncology #OncologyResearch #ClinicalTrials #ClinicalResearch #LifeScience #ClinicalInnovation #NSCLC #ElixirAssociates #StaffingPartner